ACTC

PennyMaker · Aug 23rd, 2006, 15:18

革命性的新闻！估计能到4块。stem cell近期借韩国黄的复出，有一波新的浪潮。

PennyMaker · Aug 23rd, 2006, 15:21

引用:

作者: ike

in 80k at 1.3,1.35

1.3-2.6

80k，够狠！

PennyMaker · Aug 23rd, 2006, 15:22

引用:

作者: ike

消息巨大，我的每次高几分得限价买不到，动用市价。

才买到。

近期难的的好家伙！弟兄们操家伙上！

我在1.5之前进了货，刚才加仓就加不上了。我最多加了5分都不行。

PennyMaker · Aug 23rd, 2006, 15:33

洗盘。否则根本买不到，大家都在惜卖。

PennyMaker · Sep 25th, 2006, 23:59

该公司我虽然目前没有持有，但始终在观察中，长期来讲将是一个不错的投资。Otc是鲜有好的投资（不是投机），该股是一个。

人类对疾病的征服总是无穷尽的，Stem Cell作为一把利器终将会走上属于它自己的舞台，就像今天的高科技板块一样，成为市场的主角。未来里程碑的转折在于美国对这类研究的法律的支持。

PennyMaker · Sep 26th, 2006, 00:16

Aastrom Biosciences
ASTM
Nasdaq

Advanced Cell Technology
ACTC
Nasdaq
OTC

Anormed Inc.
AOM
TSX (Toronto)

Bio-Matrix Scientific Group
BMXG
Pink Sheets

BioMS Medical
MS
TSX (Toronto)

Brainstorm Cell Therapeutics
BCLI
Nasdaq
OTC

CalbaTech
CLBE
Nasdaq
OTC

Chromos Molecular Systems
CHR
TSX
(Toronto)

Cord Blood America Inc.
CBAI
Nasdaq
OTC

Cryo-Cell International
CCEL
Nasdaq
OTC

Cryolife
CRY
NYSE

Cytori Therapeutics
CYTX
Nasdaq

EpiPharma
EPHM
Pink Sheets

Geron
GERN
Nasdaq

HepaLife Technologies
HPLF
Nasdaq
OTC

Lifecell Corp.
LIFC
Nasdaq

Mesoblast
MSB
ASX
(Australia)

MicroIslet
MII
AMEX

MultiCell Technologies
MUCL
Nasdaq
OTC

Ortec International
ORTN
Nasdaq
OTC

PharmaFrontiers
PFTR
Nasdaq
OTC

PharmaGap
GAP
TSX-Venture

Pluristem
PLRS
Nasdaq
OTC

ReNeuron
RENE
AIM
(London)

StemCells
STEM
Nasdaq

Stem Cell Therapeutics
SSS
TSX-Venture

Thermogenesis
KOOL
Nasdaq

TranXenoGen
TXN
AIM
(London)

Viacell
VIAC
Nasdaq

Vitro Diagnostics
VODG
Nasdaq
OTC

Vitrolife
VITR
Stockholm Exchange

PennyMaker · Sep 26th, 2006, 00:20

Investing in Stem Cell Research - Proceed with Caution

For companies and investors interested in stem cell research, the Nov. 3 election yielded mixed results.

The bad news was that Sen. John Kerry, who had promised to lift restrictions on stem cell research imposed by President George Bush, lost. The good news was that California passed a ballot initiative authorizing $3 billion over 10 years for stem cell research.

It wasn’t an even split, however. Kerry’s defeat and the loss of any hope that he would lift federal sanctions hammered some of the leading companies in this controversial field.

Stem Cells Controversial
Human embryonic stem cell research is controversial because it destroys embryos and some feel that is the same as taking a human life.

California, led by movie star turned governor Arnold Schwarzenegger, is betting that stem cell research and the biotechnology associated with it will be the growth industry of this decade.

The promises, yet unrealized, of the benefits of stem cell research seem too good to be true. Human embryo stem cells have the ability grow into any cell in the body.

Proponents believe that human embryonic stem cell research could lead to cures and treatment for diseases and conditions ranging from Alzheimer’s disease to paralysis.

Stem Cell Research
President Bush clamped restrictions on research in the area that has severely slowed the expansion of knowledge, according to industry and academic insiders.

There are still companies involved in stem cell research. Some are involved in researching stem cells that come from sources other than embryos. These stem cells do not have the same universal capabilities as embryonic stem cells; however, they do hold some promise in specific applications.

Human embryonic stem cell research remains controversial. It faces moral/ethic and legal obstacles that will not easily be overcome.
What Should Investors do?
How should investors approach this new industry?

First, if you have moral/ethical objections to the use of human embryos in the research, you should not invest in this industry or any business that conflicts with your core values. If you abandon your core values for a quick buck, your values aren’t worth very much.

Secondly, you should acknowledge this technology may be years from producing commercial products. This is not cutting edge, this is bleeding edge.

Thirdly, picking winners now is very difficult. Everyone wants to pick the next Microsoft or Apple in its infancy, however if you look back at the tech boom, for every survivor there are 500 companies that don’t exist anymore.
Conclusion
Stem cell research may one day lead to “miracle” cures for a variety of diseases and conditions. We just don’t know when or if that day will come and which companies will lead the way.

Sep 26th, 2006, 00:16	#6
PennyMaker Senior Member 注册日期: Jun 2005 帖子: 2,045 积分:2 精华:2 声望: 281761	目前上市的和stem cell，cell clone相关的股票 Aastrom Biosciences ASTM Nasdaq Advanced Cell Technology ACTC Nasdaq OTC Anormed Inc. AOM TSX (Toronto) Bio-Matrix Scientific Group BMXG Pink Sheets BioMS Medical MS TSX (Toronto) Brainstorm Cell Therapeutics BCLI Nasdaq OTC CalbaTech CLBE Nasdaq OTC Chromos Molecular Systems CHR TSX (Toronto) Cord Blood America Inc. CBAI Nasdaq OTC Cryo-Cell International CCEL Nasdaq OTC Cryolife CRY NYSE Cytori Therapeutics CYTX Nasdaq EpiPharma EPHM Pink Sheets Geron GERN Nasdaq HepaLife Technologies HPLF Nasdaq OTC Lifecell Corp. LIFC Nasdaq Mesoblast MSB ASX (Australia) MicroIslet MII AMEX MultiCell Technologies MUCL Nasdaq OTC Ortec International ORTN Nasdaq OTC PharmaFrontiers PFTR Nasdaq OTC PharmaGap GAP TSX-Venture Pluristem PLRS Nasdaq OTC ReNeuron RENE AIM (London) StemCells STEM Nasdaq Stem Cell Therapeutics SSS TSX-Venture Thermogenesis KOOL Nasdaq TranXenoGen TXN AIM (London) Viacell VIAC Nasdaq Vitro Diagnostics VODG Nasdaq OTC Vitrolife VITR Stockholm Exchange

Sep 26th, 2006, 00:20	#7
PennyMaker Senior Member 注册日期: Jun 2005 帖子: 2,045 积分:2 精华:2 声望: 281761	stem cell 背景资料 Investing in Stem Cell Research - Proceed with Caution For companies and investors interested in stem cell research, the Nov. 3 election yielded mixed results. The bad news was that Sen. John Kerry, who had promised to lift restrictions on stem cell research imposed by President George Bush, lost. The good news was that California passed a ballot initiative authorizing $3 billion over 10 years for stem cell research. It wasn’t an even split, however. Kerry’s defeat and the loss of any hope that he would lift federal sanctions hammered some of the leading companies in this controversial field. Stem Cells Controversial Human embryonic stem cell research is controversial because it destroys embryos and some feel that is the same as taking a human life. California, led by movie star turned governor Arnold Schwarzenegger, is betting that stem cell research and the biotechnology associated with it will be the growth industry of this decade. The promises, yet unrealized, of the benefits of stem cell research seem too good to be true. Human embryo stem cells have the ability grow into any cell in the body. Proponents believe that human embryonic stem cell research could lead to cures and treatment for diseases and conditions ranging from Alzheimer’s disease to paralysis. Stem Cell Research President Bush clamped restrictions on research in the area that has severely slowed the expansion of knowledge, according to industry and academic insiders. There are still companies involved in stem cell research. Some are involved in researching stem cells that come from sources other than embryos. These stem cells do not have the same universal capabilities as embryonic stem cells; however, they do hold some promise in specific applications. Human embryonic stem cell research remains controversial. It faces moral/ethic and legal obstacles that will not easily be overcome. What Should Investors do? How should investors approach this new industry? First, if you have moral/ethical objections to the use of human embryos in the research, you should not invest in this industry or any business that conflicts with your core values. If you abandon your core values for a quick buck, your values aren’t worth very much. Secondly, you should acknowledge this technology may be years from producing commercial products. This is not cutting edge, this is bleeding edge. Thirdly, picking winners now is very difficult. Everyone wants to pick the next Microsoft or Apple in its infancy, however if you look back at the tech boom, for every survivor there are 500 companies that don’t exist anymore. Conclusion Stem cell research may one day lead to “miracle” cures for a variety of diseases and conditions. We just don’t know when or if that day will come and which companies will lead the way.

Aug 23rd, 2006, 15:18	#1
PennyMaker Senior Member 注册日期: Jun 2005 帖子: 2,045 积分:2 精华:2	革命性的新闻！估计能到4块。stem cell近期借韩国黄的复出，有一波新的浪潮。

Aug 23rd, 2006, 15:33	#4
PennyMaker Senior Member 注册日期: Jun 2005 帖子: 2,045 积分:2 精华:2 声望: 281761	洗盘。否则根本买不到，大家都在惜卖。

Sep 25th, 2006, 23:59	#5
PennyMaker Senior Member 注册日期: Jun 2005 帖子: 2,045 积分:2 精华:2 声望: 281761	该公司我虽然目前没有持有，但始终在观察中，长期来讲将是一个不错的投资。Otc是鲜有好的投资（不是投机），该股是一个。人类对疾病的征服总是无穷尽的，Stem Cell作为一把利器终将会走上属于它自己的舞台，就像今天的高科技板块一样，成为市场的主角。未来里程碑的转折在于美国对这类研究的法律的支持。